Cargando…
Nose to brain delivery of nanosuspensions with first line antiviral agents is alternative treatment option to Neuro-AIDS treatment
Intranasal drug delivery is one of the uprising areas of the research in targeting drug to the brain. Nose to brain drug delivery follows the olfactory pathway and purportedly known to be more efficient to deliver neuro-therapeutics to the brain by circumventing the BBB and thereby increasing bioava...
Autores principales: | Kakad, Smita P., Gangurde, Trupti D., Kshirsagar, Sanjay J., Mundhe, Vaishali G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307459/ https://www.ncbi.nlm.nih.gov/pubmed/35879999 http://dx.doi.org/10.1016/j.heliyon.2022.e09925 |
Ejemplares similares
-
Nose to brain delivery of Efavirenz nanosuspension for effective neuro AIDS therapy: in-vitro, in-vivo and pharmacokinetic assessment
por: Kakad, Smita, et al.
Publicado: (2021) -
Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS
por: Sarma, Anupam, et al.
Publicado: (2020) -
Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine
por: Chen, Yingchong, et al.
Publicado: (2020) -
Development of nintedanib nanosuspension for inhaled treatment of experimental silicosis
por: Andrade da Silva, Luisa Helena, et al.
Publicado: (2022) -
Enhancement of oral bioavailability of quercetin by metabolic inhibitory nanosuspensions compared to conventional nanosuspensions
por: Li, Haowen, et al.
Publicado: (2021)